The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
Clinical trial NCT05422690 · RECRUITING
Trial details
- NCT number
- NCT05422690
- Sponsor
- Inova Health Care Services
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2027-03-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.